Navigation Links
Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
Date:3/17/2011

reduction in the use of chemotherapy after Oncotype DX testing.  The study, "German Multicentre Decision Impact Study of Oncotype DX Recurrence Score on Adjuvant Treatment in Estrogen Receptor Positive Node Negative and Node Positive Early Breast Cancer," will be presented on Thursday, March 17.
  • Spain: Results from a prospective multicenter study of 107 early-stage Spanish breast cancer patients demonstrated that the use of the Oncotype DX test changed the adjuvant treatment recommendation in approximately 32 percent of patients and that physician confidence in the treatment recommendations increased in 60 percent of cases.  The results also provided evidence on how Oncotype DX and traditional pathological factors are complementary in supporting change in treatment recommendations.  The study, "Prospective trans-GEICAM Study of the Impact of the 21-Gene Recurrence Score Assay and Traditional Clinico-Pathological Factors on Clinical Decision Making in Women with Estrogen Receptor-positive, HER2-negative, Node-negative Breast Cancer," will be presented on Thursday, March 17.
  • United Kingdom: Results based on an analysis of Oncotype DX in 107 early-stage breast cancer patients in the UK demonstrate a reduction in the use of adjuvant chemotherapy in 14 percent of patients and a change in treatment recommendations in 33 percent of cases.  Additionally, researchers found that the RS can provide UK physicians and patients with additional prognostic information beyond that currently provided by the Nottingham Prognostic Index (NPI), the current decision aid frequently used to make adjuvant breast cancer treatment decisions in the region. The researchers concluded that the results suggest that it is applicable and feasible to perform in the UK setting with a reduction in the use of adjuvant chemotherapy consistent with the findings of other reported studies. The study, "Results from a
    '/>"/>

  • SOURCE Genomic Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Reminder Webcast Alert: Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
    2. Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
    3. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
    4. Researchers use genomics to investigate TB outbreak
    5. Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17
    6. Genomic Health Announces Results from Biomarker Discovery Program Utilizing Next-Generation Sequencing to Compare Normal and Tumor Breast Tissue
    7. Sigma Life Science Collaborates with Cofactor Genomics to Develop Publically Available Rat Genome Database
    8. Four Community Hospitals Join DNA Directs Genomic Medicine Network
    9. Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
    10. Everist Genomics Announces External Validation of OncoDefender™-CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
    11. BioInformatics, LLC New Market Report - Genomics Technologies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , December 23, 2014 ... Algeria , out today and available for free download ... actors driving change and growth in the sector today. ... scored notable successes has been in developing a homegrown pharmaceutical ... percent local production still remains some way off. A cursory ...
    (Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
    (Date:12/22/2014)... Brussels (PRWEB) December 22, 2014 The ... the global leader of technical training across the life ... Clinical Data Management (SCDM) to provide the organization's ... certification programs —providing access to the more than 350 ... SCDM members with 10% off when registering for a ...
    (Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
    Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
    ...  Verenium Corporation (Nasdaq: VRNM ), a leading ... of high-performance enzymes, today announced that James Levine, Executive ... the upcoming Baird 2011 Clean Technology Conference.  The presentation ... Thursday, December 1, 2011 and will take place at ...
    ... Inc. (OTCBB: MDRM) (the "Company") is pleased to announce ... its closing agreement to acquire all of the common ... Mobility Aids, Inc. is a Nevada-based Company whose strategic ... Bio-Pharma sector as well as scalable manufacturing in niche ...
    ... Santa Barbara, Calif. Professor Kaustav Banerjee, a ... the Nanoelectronics Research Lab at the University of California, ... international research award by the Electrostatic Discharge Association (ESDA). ... competitive and meant to recognize cutting edge research ideas ...
    Cached Biology Technology:Verenium to Present at Baird Clean Technology Conference 2Verenium to Present at Baird Clean Technology Conference 3Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies 2Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies 3UCSB professor receives award for graphene electronics research 2
    (Date:11/21/2014)... DALLAS , November 18, 2014 ... Security Systems Market by Systems (Video, RFID, Access Control, ... (SEZ, Factories, Hotels, Banks, Government), Component Service Geography - ... Security Systems Market is projected to be around $25 ... Billion by 2020, growing at a CAGR of 8.69%. ...
    (Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
    (Date:11/18/2014)... 17, 2014   News Highlights: ... to develop The Partners Data Lake, an agile ... Data Lake will allow researcher and clinicians to ... and the lives of patients , The ... activities across the Partners system, breaking down physical ...
    Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
    ... the University of Leicester are investigating how the stuff of ... the human reproductive system. Hydrogen sulphide partially responsible for ... gas and has been used for chemical warfare. But ... beneficial effects it has in the body- and the potentially ...
    ... way to turn off a key signaling pathway involved in ... and other diseases. The findings may lead to new treatments ... In the study, which is currently available in the online ... that by activating a receptor in cells called the liver ...
    ... billionths of a millimeter in size. Exhibiting novel and often ... stream of equally innovative products. In medical therapies, for example, ... into cells. So far, the only way of testing these ... show the activation of a transported gene inside a ...
    Cached Biology News:UCLA researchers discover new molecular pathway for targeting cancer, disease 2Chasing tiny vehicles 2Chasing tiny vehicles 3
    ... Contents include: Microarray hybridization chamber ... chamber top, clamp, thumbscrew) Microarray chamber user ... and are intended to be cleaned and ... with Agilents Catalog Oligo Microarray kits and ...
    Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
    ... Staining Kit is a very sensitive immunohistochemical ... cells, containing both anti-von Willebrand Factor and ... a variety of species. This AP kit ... staining of frozen and paraffin-embedded sections in ...
    ... For separation ... proteins Efficient separation of nuclei ... reduction in sample complexity, greatly ... proteins Subfractionation of nucleic acid ...
    Biology Products: